Hopes and Questions raised by Alzheimer’s drug Leqembi (lecanemab)

The FDA has approved Leqem­bi, the first dis­­ease-mod­­i­­fy­ing treat­ment for ear­­ly-stage Alzheimer’s and a pre­cur­sor con­di­tion, mild cog­ni­tive impair­ment. Medicare has said it will pay for the ther­a­py. Med­ical cen­ters across the coun­try are scram­bling to final­ize poli­cies and pro­ce­dures for pro­vid­ing the med­ica­tion to patients, pos­si­bly by summer’s end or ear­ly autumn. It’s a…

Read More

Neurotech, neuroethics and brain data in context: Are “neurorights” the way to mental privacy?

Neu­rotech­nolo­gies – devices that inter­act direct­ly with the brain or ner­vous sys­tem – were once dis­missed as the stuff of sci­ence fic­tion. Not any­more. Sev­er­al com­pa­nies are try­ing to devel­op brain-com­put­er inter­faces, or BCIs, in hopes of help­ing patients with severe paral­y­sis or oth­er neu­ro­log­i­cal dis­or­ders. Entre­pre­neur Elon Musk’s com­pa­ny Neu­ralink, for exam­ple, recent­ly received…

Read More

Price tag for a questionable Alzheimer’s treatment: $109,000 per patient, per year. Unclear yet: For how many years?

The real costs of the new Alzheimer’s drug, Leqem­bi — and why tax­pay­ers will foot much of the bill (CBS News): The first drug pur­port­ing to slow the advance of Alzheimer’s dis­ease is like­ly to cost the U.S. health care sys­tem bil­lions annu­al­ly even as it remains out of reach for many of the low­er-income seniors…

Read More

Just-published Apple patent signals aim to measure brain activity using AirPods sensor system

Apple Invents a next-gen­er­a­­tion Air­Pods Sen­sor Sys­tem that could mea­sure Biosig­nals and Elec­tri­cal Activ­i­ty of a User’s brain (Patent­ly Apple): Today the US Patent & Trade­mark Office pub­lished a patent appli­ca­tion from Apple that relates to a next-gen­er­a­­tion of Air­Pods Sen­sor Sys­tem where­in the hous­ing and tips of Air­Pods could include a num­ber of active and…

Read More

Reading for pleasure during childhood may lead to higher brain/ cognitive development and mental well-being during adolescence

Ear­ly child­hood is a crit­i­cal peri­od for brain devel­op­ment, which is impor­tant for boost­ing cog­ni­tion and men­tal well­be­ing. Good brain health at this age is direct­ly linked to bet­ter men­tal heath, cog­ni­tion and edu­ca­tion­al attain­ment in ado­les­cence and adult­hood. It can also pro­vide resilience in times of stress. But, sad­ly, brain devel­op­ment can be hampered…

Read More

Virtual cognitive behavioural therapy (CBT) accounts for over 30% of NHS mental health treatments — up from 10% in 2017

Con­cern as a third of NHS men­tal health treat­ments shift online (The Guardian): An Observ­er analy­sis of data from pri­vate providers, cross-checked against NHS fig­ures, reveals around one in three men­tal health treat­ments in Eng­land are deliv­ered online, up from one in five in 2019, and one in 10 in 2017. Patients with mild to…

Read More